Bio/Pharmaceutical Community
Moving Towards an Optimized and Efficient Drug Development and Distribution System

IEEE SA is building an ecosystem of interested stakeholders from across the globe in order to address challenges of pharmaceutical value chain and positively impact patient outcomes through the creation of the Healthcare and Life Sciences Practice. 

One of Healthcare and Life Sciences (H&LS) Practice’s focus is to help drive technology innovations in order to move towards an optimized and efficient drug development and distribution system. IEEE SA’s H&LS practice is working hard to help the industry address challenges in:

  • drug research and development
  • clinical trial operations
  • patient recruitment/retention
  • tracking and security of supply chains

The average time for a drug therapy to go from R&D to market distribution is 8 to 12 years with a price tag of US$2-3 Billion. 

Join our interest list to receive notifications on the Healthcare and Life Sciences practice.